« California Hispanic Women Have the Lowest Rate Of Folic Acid Consumption
Bell’s Fishery Issues Allergy Alert On Undeclared Egg, Soy, Milk products »

FDA Issues Early Communication About Safety Review Of Aprotinin Injection

FDA issued an Early Communication about an Ongoing Safety Review of Aprotinin Injection, a drug used to control bleeding during heart surgery.

This entry was posted on Sunday, October 28th, 2007 at 11:10 pm and is filed under General. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply

You must be logged in to post a comment.